TAS
ISEE

TIFF Advisory Services’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

TIFF Advisory Services’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28,179
Closed -$164K – 25
2020
Q3 		$164K Buy
+28,179
New +$134K 0.08% 14

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TIFF Advisory Services's ISEE Position: Q4 2020 in Review

TIFF Advisory Services sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2020, closing a stake of 28,179 shares — an estimated $164K sold.

TIFF Advisory Services first reported a position in ISEE in Q3 2020 and held it in 1 quarter. The position peaked at $164K in Q3 2020. 120 funds tracked by Wall St. Rank hold ISEE as of Q4 2020.

  • TIFF Advisory Services reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • TIFF Advisory Services sold 28,179 IVERIC bio, Inc. Common Stock shares in Q4 2020, an estimated $164K.
  • TIFF Advisory Services first reported a position in IVERIC bio, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • TIFF Advisory Services's IVERIC bio, Inc. Common Stock position peaked at $164K in Q3 2020.
  • 120 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2020.

Based on TIFF Advisory Services's 13F filing for Q4 2020, filed 5 Feb 2021.